Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,507 | -77,670 | -50,532 | -70,922 | -31,594 |
| Depreciation Amortization | 6,194 | 24,853 | 18,849 | 12,784 | 6,380 |
| Accounts receivable | 6,826 | -22,382 | -15,172 | -15,259 | -4,537 |
| Accounts payable and accrued liabilities | 1,472 | 9,332 | 9,616 | 6,422 | 5,711 |
| Other Working Capital | -13,438 | -12,606 | -5,623 | -9,406 | -8,185 |
| Other Operating Activity | 4,639 | 30,845 | 7,048 | 41,967 | 10,797 |
| Operating Cash Flow | $-24,814 | $-47,628 | $-35,814 | $-34,414 | $-21,428 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,974 | -28,004 | -13,077 | -6,412 | -2,268 |
| Net Acquisitions | N/A | 2,500 | N/A | N/A | N/A |
| Purchase Of Investment | -20,509 | -49,393 | -28,257 | -25,525 | -20,593 |
| Sale Of Investment | 20,550 | 50,135 | 28,975 | 28,975 | 21,325 |
| Investing Cash Flow | $-9,933 | $-24,762 | $-12,359 | $-2,962 | $-1,536 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 15,000 | 15,000 | 15,000 | 15,000 |
| Common Stock Issued | 300 | 13,556 | 7,980 | 6,151 | 2,950 |
| Common Stock Repurchased | -2 | -16 | -14 | -11 | -6 |
| Financing Cash Flow | $298 | $28,540 | $22,966 | $21,140 | $17,944 |
| Exchange Rate Effect | 9 | 143 | -20 | 51 | -53 |
| Beginning Cash Position | 185,425 | 229,132 | 229,132 | 229,132 | 229,132 |
| End Cash Position | 150,985 | 185,425 | 203,905 | 212,947 | 224,059 |
| Net Cash Flow | $-34,440 | $-43,707 | $-25,227 | $-16,185 | $-5,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,814 | -47,628 | -35,814 | -34,414 | -21,428 |
| Capital Expenditure | -9,974 | -28,004 | -15,577 | -6,412 | -2,268 |
| Free Cash Flow | -34,788 | -75,632 | -51,391 | -40,826 | -23,696 |